Skip to content

A study comparing two adjuvants added to a local anesthetic for better pain relief during upper limb surgeries using a nerve block near the shoulder

A comparative study between dexmedetomidine and dexamethasone as adjuvants to ropivacaine in supraclavicular brachial plexus block-A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085771
Enrollment
66
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: Supraclavicular brachial plexus block is administered using ropivacaine 0.75% 20ml with 50mcg of dexmedetomidine as an adjuvant to observe the hemodynamic and analgesic

Sponsors

SRM Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA- I, II. 2.Elective surgery for fore arm, wrist, elbow and hand

Exclusion criteria

Exclusion criteria: 1.Any local infection at the site of block 2.Patients having history of hematological disorders, including coagulation abnormality 3.Pregnancy patients 4.Patient has known allergy to study drug

Design outcomes

Primary

MeasureTime frame
To compare and observe the hemodynamic profiles between dexmedetomidine and dexamethasoneTimepoint: Evaluations will be carried out at baseline before block administration, and at 5, 10, 30 minutes, and one hour after the block to assess block characteristics and hemodynamic parameters.

Secondary

MeasureTime frame
To assess the analgesic effects, postoperative hemodynamic parameters and complications.Timepoint: Every 5,10,30 minutes in the postoperative period.

Countries

India

Contacts

Public ContactDr Vishak Manoj Bhaskar

SRM medical college and hospital SRM Nagar Potheri

drcrsaravanan@gmail.com9884001153

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026